BVMF/AMGN34 (BVMF/AMGN34)

Brazil Stock Exchange: BVMF/AMGN34 · BRL

R$85.2

-0.61 (-0.7%)· Recorded snapshot

Market cap	1.3T
Revenue (ttm)	197.4B
Net income (ttm)	45.3B
EPS (ttm)	R$3.08
P/E (trailing)	27.7x
P/E (forward)	18.9x
Dividend	R$1.26 (1.48%)
Volume	88
Beta	0.41

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 197.4B
Net income (ttm): 45.3B
EPS (ttm): R$3.08
P/E (trailing): 27.7x
P/E (forward): 18.9x
Market cap: 1.3T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E18.9

P25 n/aP50 n/aP75 n/a

Trailing P/E27.7

P25 n/aP50 n/aP75 n/a

ROE91.5

P25 n/aP50 n/aP75 n/a

ROIC19.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/AMGN34 indicators

Market & fundamental data

Available fields

257

Groups with data

Currency

USD

Showing 257 of 257 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-03
Employees	31,500
Employees change	1,300
Employees growth	4.87%
Enterprise value	BRL 1.5T
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1980
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	BRAMGNBDR004
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2020-10-29
Last stock split type	Forward
Market cap	BRL 1.3T
Next earnings date	2026-11-03
Price	BRL 85.23
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	bvmf/AMGN34
Website	https://www.amgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	25.24x
Average P/E ratio (3Y)	29.44x
Average P/E ratio (5Y)	25.49x
Earnings yield	3.61%
EV/Earnings	33.7x
EV/EBIT	22.44x
EV/EBITDA	16.29x
EV/FCF	28.96x
EV/Sales	7.49x
FCF / EV yield	3.45%
FCF yield	4.07%
Forward P/E	18.88x
Graham number	16.35082
Graham upside	-80.82%
Lynch fair value	BRL 26.11
Lynch upside	-69.37%
P/(FCF - SBC) ratio	25.81x
P/(OCF - SBC) ratio	20.85x
P/B ratio	21.38x
P/E ratio	27.7x
P/FCF ratio	24.56x
P/OCF ratio	20.03x
P/S ratio	6.56x
Price/EBITDA ratio	14.47x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.4%
EBITDA margin	45.33%
Effective tax rate	15.01%
FCF margin	25.85%
Gross margin	71.89%
Operating margin	33.4%
Pretax margin	27%
Profit margin	22.95%
Profit per employee	BRL 1.4M
Profitable quarters	9
Profitable years	23
Revenue per employee	BRL 6.3M
ROA	8.67%
ROA (5Y)	8.22%
ROCE	18.14%
ROE	91.47%
ROE (5Y)	101.82%
ROIC	19.76%
ROIC (5Y)	20.52%
SBC / revenue	1.29%
Tax / revenue	4.05%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	31.6%
EPS growth (Q)	64.91%
EPS growth (QoQ)	30.84%
EPS growth 10Y	5.12%
EPS growth 3Y	2.72%
EPS growth 5Y	10.3%
EPS growth quarters	6
EPS growth years	1
FCF growth	-4.06%
FCF growth (Q)	82.58%
FCF growth (QoQ)	136.22%
FCF growth 3Y	1.66%
FCF growth 5Y	2.72%
Gross profit growth	13.09%
Gross profit growth (Q)	12.23%
Gross profit growth 3Y	11.58%
Gross profit growth 5Y	7.36%
Net income growth	32.09%
Net income growth (Q)	65.85%
Net income growth (QoQ)	30.57%
Net income growth 3Y	3.09%
Net income growth 5Y	8.76%
Net income growth quarters	6
Net income growth years	1
OCF growth	3.87%
OCF growth (Q)	75.53%
OCF growth (QoQ)	82.82%
OCF growth 10Y	2.7%
OCF growth 3Y	4.93%
OCF growth 5Y	5.48%
Operating income growth	19.55%
Operating income growth (Q)	19.33%
Operating income growth 3Y	8.67%
Operating income growth 5Y	6.56%
Revenue growth	9.1%
Revenue growth (Q)	9.53%
Revenue growth (QoQ)	16.66%
Revenue growth 10Y	5.42%
Revenue growth 3Y	12.74%
Revenue growth 5Y	8.37%
Revenue growth quarters	13
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -11.9B
Depreciation and amortization	BRL 24.3B
EBIT	BRL 65.9B
EBITDA	BRL 89.5B
EPS	BRL 3.08
Financing cash flow	BRL -21.4B
Free cash flow	BRL 52.7B
Free cash flow minus SBC	BRL 50.2B
Gross profit	BRL 141.9B
Income taxes	BRL 8B
Investing cash flow	BRL -12.4B
Net borrowing	BRL 7B
Net cash flow	BRL 30.9B
Net income	BRL 45.3B
Operating cash flow minus SBC	BRL 62.1B
Operating income	BRL 65.9B
Revenue	BRL 197.4B
Stock-based compensation	BRL 2.5B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.89
Book value per share	BRL 112.01
Debt / EBITDA	3.27
Debt / equity	4.9
Debt / FCF	5.63
Goodwill	BRL 99.9B
Interest coverage	4.14
Long-term assets	BRL 308.3B
Long-term liabilities	BRL 298.4B
Net cash (debt)	BRL -224.4B
Net cash / market cap	-17.33%
Net debt / EBITDA	2.51
Net debt / equity	3.71
Net debt / FCF	4.26
Piotroski F-Score	8
Property, plant and equipment	BRL 45.8B
Shareholders' equity	BRL 60.6B
Tangible book value	BRL -142.3B
Tangible book value per share	BRL -263.23
Total assets	BRL 495.5B
Total cash	BRL 72.5B
Total debt	BRL 296.9B
Total liabilities	BRL 434.9B
WACC	6.13%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.42
Current assets	BRL 187.1B
Current liabilities	BRL 136.5B
Current ratio	1.37
Inventory turnover	1.67
Net working capital	BRL 4.7B
Quick ratio	0.95
Working capital	BRL 49B
Working capital turnover	25.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.46%
Dividend growth	-2.46%
Dividend growth (10Y)	14.86%
Dividend growth (3Y)	7.13%
Dividend growth (5Y)	7.26%
Dividend growth years	12
Dividend payment date	2026-09-17
Dividend payment years	15
Dividend payout frequency	Quarterly
Dividend per share	BRL 1.26
Dividend yield	1.48%
Ex-dividend date	2026-08-20
Last dividend	BRL 0.31
Payout ratio	60.45%
Shareholder yield	1.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	378.98%
10Y return CAGR	19.3%
10Y total return	483.99%
150-day SMA	BRL 68.79
1D price change	-0.71%
1M price change	10.72%
1M total return	10.72%
1W price change	11.32%
1W total return	11.32%
1Y price change	46.75%
1Y return CAGR	49.46%
1Y total return	49.42%
20-day SMA	BRL 77.58
200-day SMA	BRL 68.02
3M price change	24.86%
3M total return	25.34%
3Y price change	76.5%
3Y return CAGR	23.28%
3Y total return	87.39%
50-day SMA	BRL 76.85
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 85.84
52-week high date	2026-10-26
52-week low	BRL 48.40
52-week low date	2026-01-02
5Y price change	105.62%
5Y return CAGR	17.93%
5Y total return	128.06%
6M price change	37.27%
6M total return	38.54%
All-time high	BRL 85.84
All-time high date	2026-10-26
All-time low	BRL 5.84
All-time low date	2013-02-19
Average true range (ATR)	BRL 2.60
Average volume	312.5
Beta (5Y)	0.41
Change from 52-week high	-0.71%
Change from 52-week low	76.1%
Change from all-time high	-0.71%
Change from all-time low	1,359.42%
Change from open	1.02%
Day's gap	-1.71%
Dollar volume	BRL 7,500
High price	BRL 85.39
Low price	BRL 83.79
Monthly RSI	68.49
Open price	BRL 84.37
Position in 52-week range	90%
Previous close	BRL 85.84
Price vs 150-day SMA	23.89%
Price vs 20-day SMA	9.86%
Price vs 200-day SMA	25.3%
Price vs 50-day SMA	10.9%
Relative volume	0.28
RSI	64.11
Sharpe ratio	1.02
Sharpe ratio (3Y)	0.67
Sharpe ratio (5Y)	0.47
Sortino ratio	1.65
Sortino ratio (3Y)	1.14
Sortino ratio (5Y)	0.86
Volume	88
Weekly RSI	66.12
YTD price change	29.22%
YTD total return	30.94%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	539.2M
Shares change (QoQ)	0%
Shares change (YoY)	0.46%
Shares held by insiders	0.17%
Shares held by institutions	83.82%
Short ratio	4.8 days

Deeper analysis on BVMF/AMGN34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/AMGN34 report

Is a complete BVMF/AMGN34 research report available?

No complete published report is available for bvmf/AMGN34 (BVMF/AMGN34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/AMGN34 (BVMF/AMGN34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/AMGN34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/AMGN34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/AMGN34

Frequently asked questions